A patient taking amitriptyline for abdominal pain now has bilateral foot pain that worsens in the evening, and dicyclomine is helpful but cannot be used long‑term; should the amitriptyline be discontinued and what alternative treatment is recommended for the abdominal pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Discontinue Amitriptyline and Switch to Peppermint Oil

The bilateral foot pain worsening in the evening is likely a peripheral neuropathic side effect of amitriptyline and warrants immediate discontinuation of the medication. The temporal relationship between starting amitriptyline and developing new bilateral foot pain strongly suggests drug-induced peripheral neuropathy, which can occur with tricyclic antidepressants 1.

Rationale for Discontinuation

Amitriptyline's FDA labeling warns about neurological adverse effects, and while the drug has been used for decades in neuropathic pain, the evidence base is surprisingly weak 2. The development of new neuropathic symptoms (bilateral foot pain) while on a medication that affects peripheral nerves represents a clear harm that outweighs the modest benefit ("slightly better" abdominal pain). The risk-benefit ratio has shifted unfavorably—you're trading one pain syndrome for another, potentially more debilitating one.

The anticholinergic effects of amitriptyline can also persist or fluctuate throughout long-term treatment 3, and the drug carries risks of serious complications including CNS effects and cardiac arrhythmias 4.

Recommended Alternative: Peppermint Oil

For long-term management of abdominal pain, switch to peppermint oil as your primary antispasmodic agent. The 2022 AGA guidelines specifically recommend antispasmodics for IBS-related abdominal pain, and notably state that "of the antispasmodics studied, only hyoscine, dicyclomine, and peppermint oil are available in the United States" 5, 6.

Why Peppermint Oil Over Dicyclomine Long-Term:

  • Peppermint oil can be used chronically without the same safety concerns as dicyclomine
  • Dicyclomine's anticholinergic effects (dry mouth, dizziness, blurred vision) limit long-term tolerability 6, 7
  • The FDA labeling for dicyclomine does not support extended continuous use 8
  • Antispasmodics as a class showed significant improvement in abdominal pain (RR 0.74,95% CI 0.59-0.93) 5, 6

Dosing Strategy:

  • Start peppermint oil (enteric-coated formulation) 0.2-0.4 mL three times daily, 30-60 minutes before meals
  • This provides smooth muscle relaxation and reduces visceral hypersensitivity without systemic anticholinergic burden
  • Can be used indefinitely for symptom control

Monitoring After Amitriptyline Discontinuation

Taper amitriptyline over 1-2 weeks (reduce by 25 mg every 3-4 days) rather than abrupt cessation to avoid withdrawal symptoms. The bilateral foot pain should begin improving within 2-4 weeks of complete discontinuation if it is indeed drug-induced peripheral neuropathy.

Red Flags to Watch:

  • If foot pain persists beyond 4-6 weeks after stopping amitriptyline, consider alternative etiologies (diabetic neuropathy, B12 deficiency, other metabolic causes)
  • Document baseline neurological exam now to track improvement
  • The evening worsening pattern is consistent with medication-induced neuropathy but could also represent other pathology if it doesn't resolve

Alternative Consideration If Peppermint Oil Insufficient

If peppermint oil alone doesn't provide adequate relief after 4-6 weeks:

  • Consider a trial of an SSRI (citalopram 20-40 mg daily) rather than returning to tricyclics 5, 6
  • While SSRIs showed only "possible improvement" with low certainty evidence, they lack the peripheral neuropathic risks of amitriptyline
  • SNRIs (duloxetine) may theoretically be more effective for visceral pain but lack IBS-specific trial data 5

The key principle: you cannot continue a medication that is causing new neuropathic pain while treating abdominal pain. The development of bilateral foot pain represents a clear adverse effect that compromises quality of life, and safer alternatives exist for managing functional abdominal pain.

Related Questions

In a 52-year-old patient with schizophrenia and chronic pain who is taking amitriptyline 50 mg nightly, quetiapine (Seroquel) 150 mg nightly, ziprasidone (Geodon) 160 mg nightly, and gabapentin 800 mg three times daily, and who is experiencing irritability, anger, mood lability, and severe insomnia, what medication adjustments and regimen would you recommend?
What are the alternative names (generic and brand) for hyoscine (hyoscyamine) and dicyclomine (Bentyl)?
What are the alternatives to dicyclomine (Bentyl) for treating gastrointestinal spasms?
Is amitriptyline appropriate for treating irritable bowel syndrome?
Is 10 mg of dicyclomine (anticholinergic medication) an effective and safe dose for adults?
Can Ranexa (ranolazine) tablets be crushed?
What alternative anti‑anginal agents can substitute for ranolazine (Ranexa) in chronic stable angina?
As the primary care physician, how should I interpret the imaging findings that show no mammographic or sonographic evidence of malignancy despite bilateral palpable breast concerns, and what management steps are recommended?
Should a 53-year-old patient undergo a post‑procedure mammogram after an ultrasound‑guided breast biopsy?
In a patient with pancreatic body cancer invading the celiac axis and multiple lymph node metastases, who is scheduled for palliative chemotherapy and has severe abdominal and back pain (numeric rating scale >5), what is the optimal pain control strategy?
What is the appropriate non‑oral morphine dosing regimen and pregabalin dosing schedule for an opioid‑naïve patient with pancreatic cancer pain and a pain score greater than five?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.